Tarje Onsøien Halvorsen
5PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 19, 2026
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?Frigg Å Sommervoll, Henrik Horndalsveen, Dag Einar Sommervoll
|Apr 18, 2025
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial.Tine Schytte, Marianne M Knap, Charlotte Kristiansen
|Nov 04, 2022
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.Henrik Horndalsveen, Tine Norman Alver, Astrid Marie Dalsgaard
|May 28, 2022
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.Kristin Stokke, Tarje Onsøien Halvorsen, Bjørn Henning Grønberg
|Jul 30, 2020
Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer.Tarje Onsøien Halvorsen, Christine Damgaard Valan, Marit Slaaen
Pageof 1
Frequent Collaborators
4 joint publications
Bjørn Henning Grønberg
2 joint publications
Åslaug Helland
2 joint publications
Vilde Drageset Haakensen
2 joint publications
Henrik Horndalsveen
1 joint publications
Ane L Appelt
1 joint publications
Azza Khalil
1 joint publications
Tesfaye Madebo
1 joint publications
Gitte Persson
1 joint publications
Lotte Holm Land
1 joint publications
Mikkel D Lund
